brusatol has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DL; He, JM; He, S; Jiang, R; Li, J; Lu, RJ; Ran, JH; Sun, Y; Wu, MN; Xu, H; Zhao, GZ | 1 |
| Lu, Y; Shi, Q; Wang, B; Wang, D; Wang, X; Zhu, L | 1 |
2 other study(ies) available for brusatol and Cancer of Colon
| Article | Year |
|---|---|
Brusatol Inhibits Proliferation and Metastasis of Colorectal Cancer by Targeting and Reversing the RhoA/ROCK1 Pathway.
Topics: Cadherins; Cell Movement; Cell Proliferation; Colonic Neoplasms; Humans; Neoplastic Processes; Quassins; rho-Associated Kinases; rhoA GTP-Binding Protein | 2022 |
Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells.
Topics: Cell Hypoxia; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Glucose; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Proteolysis; Quassins; Reactive Oxygen Species; Signal Transduction | 2016 |